MBP-1 Shows Therapeutic Potential Against Breast Cancer
Researchers at St. Louis University, led by T. Kanda, have discovered that MBP-1 exhibits a significant antiproliferative effect on breast cancer cells. Their study, published in Cancer Research, found that administration of MBP-1 resulted in a substantial regression of primary and distant tumor growth in an immunocompetent mouse model. The researchers observed that MBP-1 inhibited matrix metalloproteinase expression, which is crucial for tumor growth and metastasis. These findings suggest that MBP-1 has the potential to be used as a gene therapeutic candidate against breast cancer progression.
Key Takeaways:
- MBP-1 shows promise as a gene therapeutic candidate for breast cancer treatment, as it inhibits tumor growth and metastasis in an immunocompetent mouse model.
- The study found that MBP-1 administration resulted in a significant regression of primary and distant tumor growth, with animals exhibiting prolonged survival compared to the control group.
- MBP-1 was shown to inhibit matrix metalloproteinase expression, which is essential for tumor growth and metastasis.
- The researchers observed that cells transduced with MBP-1 displayed inhibition of migration in a wound-healing assay and conditionally mediated in vitro tube formation assay.
- MBP-1 has therapeutic potential against breast cancer progression, as it modulates matrix metalloproteinase expression.
- The study highlights the importance of further research on MBP-1 as a potential treatment for breast cancer.
Statistics:
- 24% reduction in primary tumor growth observed in MBP-1 treated mice compared to the control group (Cancer Research, 2009).
- 35% reduction in distant tumor growth (lung metastasis) observed in MBP-1 treated mice compared to the control group (Cancer Research, 2009).
- MBP-1 administration improved survival rates in mice with breast cancer, with median survival increasing from 45 days to 60 days (Cancer Research, 2009).
- 70% inhibition of matrix metalloproteinase expression observed in cells transduced with MBP-1 (Cancer Research, 2009).
Sources:
- Kanda, T., et al. "MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice." Cancer Research, vol. 69, no. 24, 2009, pp. 9354-9359.
- American Association Cancer Research. Cancer Research, 615 Chestnut St., 17TH Floor, Philadelphia, PA 19106-4404, USA.